FDA Inspection 1004548 — Penn Pharmaceutical Services Limited

Penn Pharmaceutical Services Limited — FEI 1000370240

The FDA completed an inspection of Penn Pharmaceutical Services Limited on March 1, 2017 in Tredegar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 1, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Tredegar (United Kingdom)

Additional Details

Postmarket Audit Inspections